American vaccines may soon get another vaccine in the fight against Corona. A single dose of the Corona vaccine, produced by American drug maker Johnson & Johnson, has been found to be up to 66% effective at preventing mild and severe illnesses during global trials.
Johnson & Johnson’s much awaited vaccine protects against corona infection in a single dose. Although it is not as strong as the two-dose vaccine, the world needs the vaccine as much as it is helpful. On Friday, the results of a trial conducted to eradicate the corona virus were presented.
On Friday, the company said that a single dose of the Corona vaccine in the US and seven other countries was 66% effective in cases of moderate to severe illness. According to the company’s statement, its impact in different regions varied. The vaccine did a great job in the US, where it is up to 72% effective against the virus.
In addition, in countries like South Africa, this vaccine was effective up to 57%. Dr. Mithai Mammon, global research head at Johnson & Johnson Company, said that gambling a single dose was actually profitable. Experts are placing more emphasis on one dose, given the barriers encountered in the path of vaccination all over the world.
The company said that it will apply for emergency use in the US within a week and then will be applied abroad. Apart from this, the company hopes that soon after getting approval in the US, its consignment will start sending out. This is a preliminary conclusion, drawn from research conducted on 44,000 volunteers and the study is not yet complete. Experts say that given the two doses being 95% effective, the question is whether low-dose supplements will be accepted.